Susquehanna Fundamental Investments, LLC Viking Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$5.19 - $6.73 $377,313 - $489,271	-72,700 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.74 - $9.67 $417,298 - $703,009	72,700 New	72,700 $460,000
Q4 2020 Feb 16, 2021	SELL	$5.3 - $6.71 $106,000 - $134,200	-20,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$5.73 - $8.11 $10,887 - $15,408	-1,900 Reduced 8.68%	20,000 $116,000
Q2 2020 Aug 14, 2020	BUY	$4.35 - $8.08 $95,264 - $176,952	21,900 New	21,900 $158,000

474

66.2M

5.72M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.18B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.